Y Intercept (Hong Kong) LTD Olema Pharmaceuticals, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 10,882 shares of OLMA stock, worth $48,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,882
Previous 19,001
42.73%
Holding current value
$48,098
Previous $110,000
63.64%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding OLMA
# of Institutions
135Shares Held
64.3MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$30.3 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$29.8 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$23.4 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$17.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$15.2 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $179M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...